| Meridian Illinois Medicaid Clinical | Infectious Disease: Multisystem Lab Testing (CG.CP.MP.02) | 2024-02-01 |
| Meridian Illinois Medicaid Clinical | Infectious Disease: Primary Care & Preventive Lab Screening (CG.CP.MP.05) | 2024-02-01 |
| Meridian Illinois Medicaid Clinical | Infectious Disease: Respiratory Lab Testing (CG.CP.MP.01) | 2024-02-01 |
| Meridian Illinois Medicaid Clinical | Infectious Disease: Vector-borne and Tropical Diseases Lab Testing (CG.CP.MP.06) | 2024-02-01 |
| Meridian Michigan Medicaid Clinical | Long Term Care Placement | 2024-02-01 |
| Meridian Michigan Medicaid Clinical | Tandem Transplant | 2024-02-01 |
| Meridian Illinois Medicaid Clinical | Duplicate Therapy | 2024-01-31 |
| HealthPartners | Habilitative therapies | 2024-01-30 |
| Medicare CGS | Billing and Coding: MolDX: Microsatellite Instability-High (MSI-H) and Mismatch Repair Deficient (dMMR) Biomarker for Patients with Unresectable or Metastatic Solid Tumors (56106) | 2024-01-30 |
| Meridian Illinois Medicaid Clinical | Treprostinil (Orenitram, Remodulin, Tyvaso, Tyvaso DPI) | 2024-01-29 |